American Journal of Medical Genetics Part A· 2026Q2
Neurobehavioral Profiles and Clinical Consequences of MYT1L ‐Related Neurodevelopmental Disorder: Insights From the Brain Gene Registry
- 2citations
- Q2SCImago
- 2026year
Short summary
A prospective analysis of 25 individuals with MYT1L-NDD, using the Brain Gene Registry, reveals significant impairments in nonverbal cognition and adaptive skills (motor, communication, daily living), alongside elevated rates of autism, ADHD, conduct problems, and anxiety.
AI-generated from the title and abstract; the full text is not read.
Key points
- MYT1L-NDD patients exhibit significant impairments in nonverbal cognition and adaptive functioning.
- Elevated rates of autism symptoms, ADHD, conduct problems, and anxiety were observed.
- Common clinical diagnoses include developmental delays, intellectual disability, GI problems, and obesity.
- The Brain Gene Registry (BGR) facilitated this first prospective, multi-source phenotyping.
AI-generated from the title and abstract; the full text is not read.
Abstract
MYT1L-Related Neurodevelopmental Disorder (MYT1L-NDD) is a rare autosomal dominant syndrome characterized by intellectual disability, global developmental delay, autism, and obesity. Despite growing recognition, prospective and systematic clinical phenotyping remains limited. Here, we present an exploratory analysis of data from 25 individuals with MYT1L-NDD enrolled in the Brain Gene Registry (BGR), a national platform integrating genetic, neurobehavioral, and clinical data. Neurobehavioral assessments were conducted using the Rapid Neurobehavioral Assessment Protocol (RNAP), including virtual adaptations of the Shipley, Developmental Profile-4, ASEBA Child Behavior Checklist, and Vineland-3. Diagnostic and medication data were extracted from structured electronic health records (EHR). MYT1L-NDD participants were compared to the broader BGR cohort. MYT1L-NDD participants exhibited pronounced impairments in nonverbal cognition and adaptive functioning, particularly in motor tasks, communication, and daily living skills. Behavioral assessments revealed elevated rates of autism symptoms, ADHD symptoms, behavioral conduct problems, oppositional defiance, and anxiety. EHR diagnosis data were available for 10 MYT1L-NDD participants. It showed frequent diagnoses of developmental delays, speech and language disorders, intellectual disability, gastrointestinal problems, and obesity. Medication data on five participants indicated common prescription of alpha-2 adrenergic agonists and laxatives. This study provides the first prospective, multi-source characterization of MYT1L-NDD. Findings expand our understanding of MYT1L-NDD phenotypes in a quantitative and systematic manner and support the value of registry-based approaches for understanding rare neurodevelopmental disorders. Larger, longitudinal, age-stratified studies are needed to further define MYT1L-NDD natural history and inform clinical care.
The authors' abstract, as published at the source. American Journal of Medical Genetics Part A, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Genetics (Biochemistry, Genetics and Molecular Biology)
GeneticsBiochemistry, Genetics and Molecular Biology